PENG vs Femoral Block for Hip Fracture Analgesia
ConditionHip Fractures
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University
About this trial
This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.
Eligibility criteria
Qualifiers
Male or female ≥ 18 years of age.
ASA Classification 1-4
Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location
Written, informed consent for analgesic peripheral block placement
Disqualifiers
Altered mental status to the extent that it limits ability to report pain score
Patient or health care proxy refusal of analgesic nerve block
Allergy to study medications or contraindication to peripheral nerve block
Peri-prosthetic fracture
Trial design
Treatments tested in this trial
- PENG Block Administration
- Femoral Block Administration
- Bupivacaine , epinephrine Dexamethasone
Treatment groups
352 Participants
are divided into 2 treatment groupsSponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
New York Presbyterian Hospital
Collaborator
Source ClinicalTrials.gov